Benzinga - Jun 10, 2021, 7:33AM
Benzinga - May 10, 2021, 4:17PM
Benzinga - Apr 12, 2021, 9:44AM
Benzinga - Apr 12, 2021, 9:38AM
Benzinga - Apr 12, 2021, 8:28AM
Benzinga - Apr 12, 2021, 7:22AM
Benzinga - Apr 12, 2021, 6:42AM
Benzinga - Mar 19, 2021, 1:52PM
Benzinga - Mar 18, 2021, 11:13AM
Benzinga - Mar 18, 2021, 9:08AM
Benzinga - Mar 18, 2021, 7:12AM
Gain Therapeutics Inc is a development-stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (LSDs), including rare genetic diseases and neurological disorders. Its pipeline includes the GLB1 gene, GBA1 gene, IDUA gene, and GALC gene.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-29
REV
Q1 2021Est.ActualSurprise
EPS-0.190-0.500 -0.3100
REV5.269M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GANXGain Therapeutics-1.49%

Gain Therapeutics Frequently Asked Questions

Q

How do I buy Gain Therapeutics (GANX) stock?

A

You can purchase shares of Gain Therapeutics (NASDAQ: GANX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Gain Therapeutics's (GANX) competitors?

A

There are no as such competitors for Gain Therapeutics.

Q

What is the target price for Gain Therapeutics (GANX) stock?

A

The latest price target for Gain Therapeutics (NASDAQ: GANX) was reported by Oppenheimer on April 12, 2021. The analyst firm set a price target for 30.00 expecting GANX to rise to within 12 months (a possible 223.97% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Gain Therapeutics (GANX)?

A

The stock price for Gain Therapeutics (NASDAQ: GANX) is $9.26 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Gain Therapeutics (GANX) pay a dividend?

A

There are no upcoming dividends for Gain Therapeutics.

Q

When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?

A
Gain Therapeutics’s Q2 earnings are confirmed for after-market on July 29, 2021.
Q

Is Gain Therapeutics (GANX) going to split?

A

There is no upcoming split for Gain Therapeutics.

Q

What sector and industry does Gain Therapeutics (GANX) operate in?

A

Gain Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.